The fate of metronidazole and tis implications in chemotherapy
- PMID: 1154802
- DOI: 10.3109/00498257509052069
The fate of metronidazole and tis implications in chemotherapy
Abstract
1. [14C]Metronidazole was rapidly absorbed from the gastro-intestinal tract of rats giving maximum blood levels of radioactivity, equivalent to 6-4 and 6-7 mug metronidazole per ml blood, 1 h after oral dosing. 2. There was rapid equilibration between blood and most tissues, although radioactivity was concentrated in the liver, kidney, gastro-intestinal tract and vaginal secretions. 3. The half-life of clearance of radioactivity from the majority of tissues was between 3 and 4 h, although it was longer in the skin (8 h) and gastro-intestinal tract (14 h). 4. Fourteen radioactive excretion products were detected in rat urine and all the major products were identified. These all contained a nitro group and represented 97 degrees of the total radioactivity excreted in urine. 5. Unchanged metronidazole was secreted throughout the entire length of the gastro-intestinal tract and into the vagina of rats. 6. A hypothesis has been proposed to explain the high clinical efficacy of metronidazole in treating trichomonal and amoebic infections.
Similar articles
-
Fate of metronidazole following intravaginal and intravenous administration to rabbits.J Toxicol Environ Health. 1982 Feb;9(2):305-16. doi: 10.1080/15287398209530163. J Toxicol Environ Health. 1982. PMID: 7077685
-
Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.Arzneimittelforschung. 1994 Apr;44(4):527-38. Arzneimittelforschung. 1994. PMID: 7912071
-
Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.Arzneimittelforschung. 1990 Jul;40(7):800-5. Arzneimittelforschung. 1990. PMID: 2222556
-
Clinical pharmacokinetics of metronidazole.Clin Pharmacokinet. 1983 Jan-Feb;8(1):43-62. doi: 10.2165/00003088-198308010-00003. Clin Pharmacokinet. 1983. PMID: 6340904 Review. No abstract available.
-
Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.Clin Pharmacokinet. 1999 May;36(5):353-73. doi: 10.2165/00003088-199936050-00004. Clin Pharmacokinet. 1999. PMID: 10384859 Review.
Cited by
-
A comparison of clinical outcomes associated with dosing metronidazole every 8 hours versus every 12 hours: a systematic review and metaanalysis.Proc (Bayl Univ Med Cent). 2023 Dec 20;37(1):127-134. doi: 10.1080/08998280.2023.2282144. eCollection 2024. Proc (Bayl Univ Med Cent). 2023. PMID: 38174024 Free PMC article. Review.
-
Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile.Gut. 1986 Oct;27(10):1169-72. doi: 10.1136/gut.27.10.1169. Gut. 1986. PMID: 3781329 Free PMC article.
-
Disposition of oral metronidazole in hepatic cirrhosis and in hepatosplenic schistosomiasis.Gut. 1982 Oct;23(10):807-13. doi: 10.1136/gut.23.10.807. Gut. 1982. PMID: 7117899 Free PMC article.
-
Relation between concentrations of metronidazole and Bacteroides spp in faeces of patients with Crohn's disease and healthy individuals.J Clin Pathol. 1981 Jun;34(6):645-50. doi: 10.1136/jcp.34.6.645. J Clin Pathol. 1981. PMID: 7251906 Free PMC article.
-
Mechanism of toxicity of nitro compounds used in the chemotherapy of trichomoniasis.Environ Health Perspect. 1985 Dec;64:199-208. doi: 10.1289/ehp.8564199. Environ Health Perspect. 1985. PMID: 3830698 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources